Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)

Carboxypeptidase G2 (CP) is a bacterial enzyme, which is targeted to tumours by an antitumour antibody for local prodrug activation in antibody-directed enzyme prodrug therapy (ADEPT). Repeated cycles of ADEPT are desirable but are hampered by human antibody response to CP (HACA). To address this, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, A, Sharma, S K, Tolner, B, Minton, N P, Purdy, D, Amlot, P, Tharakan, G, Begent, R H J, Chester, K A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409521/
https://www.ncbi.nlm.nih.gov/pubmed/15162148
http://dx.doi.org/10.1038/sj.bjc.6601888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409521/
https://www.ncbi.nlm.nih.gov/pubmed/15162148
http://dx.doi.org/10.1038/sj.bjc.6601888

Ejemplares similares